Drug transport in the mammalian central nervous system: Multiple complex systems. A critical analysis and commentary

Pharmacology

Volumn 60, Issue 2, 2000, Pages 58-73

  Spector, Reynold ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Active transport; Ascorbic acid; Cerebral capillaries; Choroid plexus; Facilitated diffusion; Folate; Homeostasis; Nucleosides; Penicillin; Receptor mediated transport

Indexed keywords

AMANTADINE; AMINO ACID; AMPHETAMINE; ASCORBIC ACID; CEFTRIAXONE; CEPHALOSPORIN; DIGOXIN; DIPHENHYDRAMINE; DOXORUBICIN; DRUG CARRIER; FOLIC ACID; GLUTATHIONE DERIVATIVE; IODIDE; IVERMECTIN; LEUKOTRIENE C4; LEVODOPA; LIDOCAINE; METHYLDOPA; MULTIDRUG RESISTANCE PROTEIN; NUCLEOSIDE; PENICILLIN G; PERCHLORATE; THYMIDINE; THYROID HORMONE; URIDINE; VINCRISTINE; VITAMIN; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DIFFUSION; DRUG TRANSPORT; HOMEOSTASIS; HUMAN; HUMAN TISSUE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

EID: 0033956508     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028349     Document Type: Review

References (69)

1. Vesell ES, Beam AG: Localization oflactic acid dehydrogenase activity in serum fractions. Proc Soc Exp Biol Med 1957;94:96-99.
2. Davson H, Malcolm BS: Physiology of the CSF and Blood-Brain Barriers. Boca Raton, CRC Press, 1996.
3. Spector R: Drug transport in the central nervous system: Role of carriers. Pharmacology 1990;40:1-7.
4. Spector R: Vitamin homeostasis in the central nervous system. N Engl J Med 1977;296:1393-1398.
5. Spector R, Lorenzo AV: The effects of salicylate and probenecid on the cerebrospinal fluid transport of penicillin, aminosalicylic acid and iodide. J Pharmacol Exp Ther 1974;188:55-65.
6. Spector R, Lorenzo AV: Inhibition of penicillin transport from the cerebrospinal fluid after intracranial inoculation of bacteria. J Clin Invest 1974;54:316-325.
7. Bradbury MW: Physiology and pharmacology of the blood-brain barrier. Berlin, Springer, 1992.
8. Spector R: Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J Neurochem 1989;53:1667-1674.
9. Spector R, Johanson CE: The mammalian choroid plexus: Structure, development and function. Sci Am 1989;Nov:68-74.
10. Christensen HN: Biological Transport. Reading, Benjamin, 1975.
11. Stein WE: Transport and Defussion Across Cell Membranes. Orlando, Academic Press, 1986.
12. Antony AC: Folate receptors. Annu Rev Nutr 1996;16:501-521.
13. Spector R: Nucleoside transport in choroid plexus: Mechanism and specificity. Arch Biochem Biophys 1982;216:693-703.
14. Abe T, Kakyo M, Sakagami H, et al: Molecuar characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 1998;273:22395-22401.
15. Nishino J, Suzuki H, Sugiyama D, et al: Transepithelial transport of organic anions across the choroid plexus: Possible involvement of organic anion transporter and multidrug resistance-associated protein. J Pharmacol Exp Ther 1999;290:289-294.
16. 14C)-labelled ascorbic acid and dehydroascorbic acid. Acta Physiol Scand 1966;70(suppl 289):1-70.
17. Agus DB, Gamhir SS, Pardridge WM, et al: Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 1997;100:2842-2848.
18. Dhariwal KR, Hartzell WO, Levine M: Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 1991;54:712-716.
19. Schinkel AH: P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Delivery Rev 1999;36:179-194.
20. Wood M: Editorial review - Plasma binding and limitation of drug access to site of action. J Anesthesiol 1991;75:721-723.
21. Marathe PH, Shen DD, Artru AA, et al: Effect of serum protein binding on the entry of lidocaine into brain and cerebrospinal fluid in dogs. Anesthesiology 1991;75:804-812.
22. Bass L, Pond SM: The puzzle of rates of cellular uptake of protein-bound ligands. Life Sci 1988; 145:245-269.
23. Mendel CM: The free hormone hypothesis: A physiologically based mathematical model. Endocr Rev 1989;10:232-274.
24. Pardridge WM: Introduction to the Blood-Brain Barrier. Methodology. Biology and Pathology. Cambridge, Cambridge University Press, 1998.
25. Williams SAT, Segal MB: Identification of a saturable uptake system for deoxyribonucleosides at the blood-brain and blood-cerebrospinal fluid barriers. Brain Res 1996;741:230-239.
26. Gutmann H, Torok M, Fricker G, et al: Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metabol Disp 1999;27:937-941.
27. Terasaki T, Hosoya K: The blood-brain barrier efflux transporters as a detoxifying system for the brain. Adv Drug Deliv Rev 1999;36:195-209.
28. Hakvoort A, Haselback M, Galla HJ: Active transport properties of porcine choroid plexus cells in culture. Brain Res 1998;795:247-256.
29. Spector R: Ceftriaxone transport through the blood-brain barrier. J Infect Dis 1987;156: 209-211.
30. Suzuki H, Trasaki T, Sugiyama Y: Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system. Adv Drug Deliv Rev 1997;25: 257-285.
31. Suzuki H, Sawada Y, Sugiyama Y, et al: Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. J Pharmacol ExpTher 1989;250:979-984.
32. Angeletti RH, Novikoff PM, Juvvadi SR, et al: The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc Natl Acad Sci USA 1997;94:283-286.
33. Rao VV, Dahlheimer JL, Bardgett ME, et al: Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999;96:3900-3905.
34. Spector R, Goetzl EJ: Role of concentrative leukotriene transport systems in the central nervous system. Biochem Pharmacol 1986;35: 2849-2853.
35. Angeletti RH, Bergwerk AJ, Novikoff PM, Wolkoff AW: Dichotomous development of the organic anion transport protein in liver and choroid plexus. Am J Physiol 1998;275:C882-C887.
36. Spector R, Lorenzo AV: Ascorbic acid homeostasis in the central nervous system. Am J Physiol 1973;225:757-763.
37. Spector R, Lorenzo AV: The specificity of ascorbic acid transport system of the central nervous system. Am J Physiol 1974;226:1468-1473.
38. Spector R: Penetration of ascorbic acid from cerebrospinal fluid into brain. Exp Neurol 1981;72:645-653.
39. Lam DKC, Daniel PM: The influx of ascorbic acid into the rat's brain. J Exp Physiol 1986;71: 483-489.
40. Spector R: Development of the vitamin transport systems in choroid plexus and brain. J Neurochem 1979;33:1317-1319.
41. Spector R, Lorenzo AV: Folate transport in the central nervous system. Am J Physiol 1975; 229:777-782.
42. Spector R, Lorenzo AV: Folate transport by the choroid plexus in vitro. Science 1975;185:540-542.
43. Suleiman SA, Spector R: Purification and characterization of a folate binding protein from porcine choroid plexus. Arch Biochem Biophys 1981;208:87-94.
44. Suleiman SA, Spector R, Cancilla P: Partial purification and characterization of a folate binding protein from human choroid plexus. Neurochem Res 1981;6:333-341.
45. Patrik TA, Kranz DM, van Dyke TA, Roy EJ: Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J Neuro-Oncol 1997;32:111-123.
46. Reddy JA, Low PS: Folate-mediated targeting of therapeutic and imaging agents to cancers. Ther Drug Carrier Systems 1998;15:587-627.
47. Wu D, Pardridge WM: Blood-brain barrier transport of reduced folic acid. Pharmaceut Res 1999;16:415-419.
48. Prasad PD, Ramamoorthy S, Leibach FH, Ganapathy V: Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun 1995;206:681-687.
49. Spector R: Cerebrospinal fluid folate and the blood-brain barrier: in Botez MI, Reynolds EH (eds): Folic Acid in Neurology, Psychiatry, and Internal Medicine. New York, Raven Press, 1979.
50. Suleiman SA, Spector R: Identification, development and regional distribution of thymidylate synthetase in adult rabbit brain. J Neurochem 1982;38:392-396.
51. Eells JT, Spector R: Identification, development and regional distribution of ribonucleotide reductase in adult rat brain. J Neurochem 1983;40:1008-1012.
52. Eells JT, Spector R, Huntoon S: Nucleoside and oxypurine homeostasis in adult rabbit cerebrospinal fluid and plasma. J Neurochem 1984;42:1620-1624.
53. Wu D, Clement JG, Pardridge WM: Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat. Brain Res 1998;791:313-316.
54. Washington CB, Giacomini KM, Brett CM: Nucleoside transport in isolated human and rhesus choroid plexus tissue slices. Pharmaceut Res 1998;15:1145-1147.
55. Griffith DA, Jarvis SM: Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1996;1286:153-181.
56. Spector R: Thymidine transport in the central nervous system. J Neurochem 1980;35:1092-1098.
57. Spector R: Uridine transport and metabolism in the central nervous system. J Neurochem 1985;45:1411-1418.
58. Strazielle N, Ghersi-Egea JF: Demonstration of a coupled metabolism-efflux process at the choroid plexus and a mechanism of brain protection toward xenobiotics. J Neurosci 1999; 19:6275-6289.
59. Spector R, Huntoon S: Specificity and sodium-dependence of the active nucleoside transport system in choroid plexus. J Neurochem 1984; 42:1048-1052.
60. Nilsson C, Lindvall-Axelsson L, Owman C: Neuroendocrine regulatory mechanisms in the choroid plexus-cerebrospinal fluid system. Brain Res Rev 1992;17:109-138.
61. Hagen GA, Elliott WJ: Transport of thyroid hormones in serum and cerebrospinal fluid. J Clin Endocrinol Metab 1973;37:415-422.
62. Hagen GA, Solberg LA Jr: Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 1974;95:1398-1410.
63. Spector R, Levy P: Thyroxine transport by the choroid plexus in vitro. Brain Res 1975;98: 400-404.
64. Pardridge WM: Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier: Primary role of albumin-bound hormone. Endocrinology 1979;105:605-612.
65. Zheng W, Zhao Q, Graziano JH: Primary culture of choroidal epithelial cells: Characterization of an in vitro model of blood-CSF barrier. In Vitro Cell Dev Biol 1998;34:40-45.
66. Southwell BR, Duan W, Alcorn D, et al: Thyroxine transport to the brain: Role of protein synthesis by the choroid plexus. Endocrinology 1993;133:2116-2125.
67. Episkopou V, Maeda S, Nishiguchi S, et al: Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 1993; 90:2375-2379.
68. Palha JA, Episkopou V, Maeda S, et al: Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 1994;269: 33135-33139.
69. Zheng W, Blaner WS, Zhao Q: Inhibition by lead of production and secretion of transthyretin in the choroid plexus: Its relation to thyroxine transport at blood-CSF barrier. Toxicol Applied Pharmacol 1999;155:24-31.